Decision to list medical devices supplied by Obex Medical Limited

Hospital devices

Decision

PHARMAC is pleased to announce approval of the amendment to the non-exclusive listing of a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 November 2019, through an agreement with Obex Medical Limited.

The devices are in the following categories:

  • orthopaedic implants and associated products (“Orthopaedic Products”);
  • respiratory equipment and consumables (“Respiratory Care Products”);
  • endomechanical and electrosurgical products (Endomechanical and Electrosurgical Products"; and
  • non-invasive ventilation products (“NIV Products”).

This will result in 250 of Obex’s medical devices, across these categories, being listed in Part III of Section H of the Pharmaceutical Schedule from 1 November 2019.

DHBs will be able to continue to purchase other suppliers’ brands of Orthopaedic Products, Respiratory Care Products, endomechanical and electrosurgical products, and NIV Products as the agreement is not for sole supply.

What would the effect be?

This decision was subject to a consultation letter dated 4 September 2019

No changes have been made to the agreement as a result of the consultation feedback.

Who we think will be most interested

  • Suppliers and wholesalers
  • DHB staff:
    • clinical staff in a range of inpatient, outpatient and community settings where these medical devices are used
    • surgeons
    • perioperative personnel
    • sterile services personnel
    • respiratory therapists
    • respiratory and sleep clinic specialists and support personnel
    • pulmonary rehabilitation specialists
    • clinical/biomedical Engineers
    • procurement and supply chain personnel

Details about this decision

PHARMAC issued Request for Proposals (“RFP’s”) for:

The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

Following evaluation of Obex’s proposal to each RFP, and consultating on the provisional agreement reached, PHARMAC has decided to list Obex’s range of orthopaedic products, respiratory care products, endomechanical and electrosurgical products, and NIV Products in Part III of Section H of the Pharmaceutical Schedule from 1 November 2019.

The brands and number of products per category included in the Agreement are:

Category

Line items

Brands

Orthopaedic Products

13

Summit

Respiratory Care Products

133

AirLife

Cook Medical

Meditech Systems Asia Pacific

Meditech Systems Ltd

Mercury Medical

Vyaire Medical

WELL LEAD

Endomechanical and electrosurgical products

63

BEMA

Electro Lube ®

HolstOR

KLS Martin

Matrix Surgical

Sutter

Trokamed

X-One

NIV Products

41

AirLife

Meditech Systems Asia Pacific

Vyaire Medical

DHBs that purchase these categories of medical devices from Obex must do so under the terms and conditions, and the prices included in the agreement from the listing date. DHBs can continue to choose which orthopaedic products, respiratory care products, endomechanical and electrosurgical products, and NIV Products they purchase.

The agreement includes terms and conditions for training and education to be provided by Obex, on the appropriate use of their products, which is to be provided at times as agreed with individual DHBs.

Our response to what you told us

We appreciate the time people took to respond to this consultation.

All consultation responses received by 4pm on Wednesday 25 September 2019 were considered in their entirety in making the decision to approve this agreement.

A summary of the main themes raised in feedback and our responses to the feedback are set out below:

Theme

Comment

No technical or resource impacts are expected as a result of the proposal.

Noted.

Noted that some DHB volume and expenditure data provided to DHB Procurement Managers for Obex’s NIV Products and Endomechanical and Electrosurgical Products lacked some detail or required further clarification for validation purposes.

Updated DHB volume and expenditure data for NIV Products and Endomechanical and Electrosurgical Products was requested from Obex and provided to appropriate DHB personnel prior to closure of the consultation.

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.